503 related articles for article (PubMed ID: 23818691)
1. Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects.
Remme CA
J Physiol; 2013 Sep; 591(17):4099-116. PubMed ID: 23818691
[TBL] [Abstract][Full Text] [Related]
2. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.
Wilde AAM; Amin AS
JACC Clin Electrophysiol; 2018 May; 4(5):569-579. PubMed ID: 29798782
[TBL] [Abstract][Full Text] [Related]
3. Biophysical mechanisms of myocardium sodium channelopathies.
Zaytseva AK; Kulichik OE; Kostareva AA; Zhorov BS
Pflugers Arch; 2024 May; 476(5):735-753. PubMed ID: 38424322
[TBL] [Abstract][Full Text] [Related]
4. Clinical Spectrum of
Villarreal-Molina T; García-Ordóñez GP; Reyes-Quintero ÁE; Domínguez-Pérez M; Jacobo-Albavera L; Nava S; Carnevale A; Medeiros-Domingo A; Iturralde P
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052356
[TBL] [Abstract][Full Text] [Related]
5. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
6. Cardiac sodium channelopathies.
Amin AS; Asghari-Roodsari A; Tan HL
Pflugers Arch; 2010 Jul; 460(2):223-37. PubMed ID: 20091048
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations.
Remme CA; Wilde AA; Bezzina CR
Trends Cardiovasc Med; 2008 Apr; 18(3):78-87. PubMed ID: 18436145
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Arrhythmias Related to Sodium Channel Dysfunction.
Savio-Galimberti E; Argenziano M; Antzelevitch C
Handb Exp Pharmacol; 2018; 246():331-354. PubMed ID: 28965168
[TBL] [Abstract][Full Text] [Related]
9. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
[TBL] [Abstract][Full Text] [Related]
10. Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A.
Kanters JK; Yuan L; Hedley PL; Stoevring B; Jons C; Bloch Thomsen PE; Grunnet M; Christiansen M; Jespersen T
Circ J; 2014; 78(5):1136-43. PubMed ID: 24599044
[TBL] [Abstract][Full Text] [Related]
11. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
[TBL] [Abstract][Full Text] [Related]
12. Channelopathies from mutations in the cardiac sodium channel protein complex.
Adsit GS; Vaidyanathan R; Galler CM; Kyle JW; Makielski JC
J Mol Cell Cardiol; 2013 Aug; 61():34-43. PubMed ID: 23557754
[TBL] [Abstract][Full Text] [Related]
13. Heritable arrhythmia syndromes associated with abnormal cardiac sodium channel function: ionic and non-ionic mechanisms.
Rivaud MR; Delmar M; Remme CA
Cardiovasc Res; 2020 Jul; 116(9):1557-1570. PubMed ID: 32251506
[TBL] [Abstract][Full Text] [Related]
14. SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.
Musa H; Kline CF; Sturm AC; Murphy N; Adelman S; Wang C; Yan H; Johnson BL; Csepe TA; Kilic A; Higgins RS; Janssen PM; Fedorov VV; Weiss R; Salazar C; Hund TJ; Pitt GS; Mohler PJ
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12528-33. PubMed ID: 26392562
[TBL] [Abstract][Full Text] [Related]
15. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.
Beyder A; Mazzone A; Strege PR; Tester DJ; Saito YA; Bernard CE; Enders FT; Ek WE; Schmidt PT; Dlugosz A; Lindberg G; Karling P; Ohlsson B; Gazouli M; Nardone G; Cuomo R; Usai-Satta P; Galeazzi F; Neri M; Portincasa P; Bellini M; Barbara G; Camilleri M; Locke GR; Talley NJ; D'Amato M; Ackerman MJ; Farrugia G
Gastroenterology; 2014 Jun; 146(7):1659-1668. PubMed ID: 24613995
[TBL] [Abstract][Full Text] [Related]
16. Inter-Regulation of K
Clatot J; Neyroud N; Cox R; Souil C; Huang J; Guicheney P; Antzelevitch C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709127
[TBL] [Abstract][Full Text] [Related]
17.
Remme CA
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220164. PubMed ID: 37122208
[TBL] [Abstract][Full Text] [Related]
18. SCN5A-L256del and L1621F exhibit loss-of-function properties related to autosomal recessive congenital cardiac disorders presenting as sick sinus syndrome, dilated cardiomyopathy, and sudden cardiac death.
Shi J; Pan X; Wang Z; Yi M; Xie S; Zhang X; Tao D; Yang Y; Liu Y
Gene; 2024 Mar; 898():148093. PubMed ID: 38123004
[TBL] [Abstract][Full Text] [Related]
19. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients.
Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH
Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085
[TBL] [Abstract][Full Text] [Related]
20. Bringing home the bacon? The next step in cardiac sodium channelopathies.
Wilde AA; Postema PG
J Clin Invest; 2015 Jan; 125(1):99-101. PubMed ID: 25500878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
